LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Health & Fitness
• Education
• Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

cancer, patients, breast, plr, til, article, tils, nlr, google, scholar, immune, ratio, tumor, cells, cas, lymphocytes, tnbc, group, triplenegative, prognostic, data, cell, high, platelettolymphocyte, blood, tumorinfiltrating, relationships, groups, distant, study, peripheral, outcomes, neutrophiltolymphocyte, chemotherapy, mfihc, correlation, tcells, analysis, patient, tumors, additional, survival, factor, subtypes, file, stromal, horimoto, infiltration, tcell, metastatic,

Topics {✒️}

cd3+cd4+foxp3+ t-cell detections cd3+cd4+foxp3+ t-cells retained cd3+cd4+foxp3+ t-cell infiltration cd3+cd4+t-bet+ t-cells anti-pd-l1 monoclonal antibody cd3+cd4+foxp3+ t-cells cd3+cd4+ t-lymphocyte infiltration triple-negative breast cancers triple-negative breast cancer multiplexed fluorescent immunohistochemistry lymphocyte-predominant breast cancer t-cell lymphocyte infiltrations cd3+cd4+t-bet+ t-cell lymphocyte infiltration pre-treatment neutrophil-lymphocyte ratio breast cancer-related deaths cd8+ t-cell infiltration cd8+ t-cell counts cd3+cd8+ t-cells her2/neu gene amplification activated cd8 t-cells pd-l1 protein expression pd-l1 expression tended cd8-positive t-cells [34 received pre-operative chemotherapy platelet-lymphocyte cross-talk drew kaplan–meier curves regulatory t-cell regulatory t-cells degranulation induce pro-survival luminal her2-negative [lum] junichiro watanabe cell signaling technology til-high/plr-low group til-low/plr-high group advanced medical development cdk4/6 inhibitor-based treatments reflecting local tumor-immunity cd4+ t-cells article download pdf luminal her2-positive [lumh] national cancer center tumor-infiltrating lymphocytes longest distant metastasis-free distant metastasis-free survival distant metastasis-free-survival full access luminal her2-negative privacy choices/manage cookies triple-negative tnbc

Schema {🗺️}

WebPage:
      mainEntity:
         headline:High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs
         description:Rating lymphocytes (TILs) are a prognostic marker in breast cancer and high TIL infiltration correlates with better patient outcomes. Meanwhile, parameters involving immune cells in peripheral blood have also been established as prognostic markers. High platelet-to-lymphocyte ratios (PLRs) and neutrophil-to-lymphocyte ratios (NLRs) are related to poor outcomes in breast cancer, but their mechanisms remain unknown. To date, TILs and these parameters have been examined separately. We investigated the relationship between TILs and the peripheral blood markers, PLR and NLR, in the same patients, using surgical specimens from 502 patients with invasive breast carcinoma without preoperative chemotherapy. For analysis of triple-negative breast cancer (TNBC) patient outcomes, 59 patients who received preoperative chemotherapy were also examined. For immune cell profiling, multiplexed fluorescent immunohistochemistry (mfIHC) of CD3, CD4, CD8, FOXP3 and T-bet, was conducted. A positive correlation between PLR and TIL was observed in TNBC (P = 0.013). On mfIHC, tumors in patients with high PLR and NLR contained more CD3+CD4+FOXP3+ T-cells (P = 0.049 and 0.019, respectively), while no trend was observed in CD8+ T-cells. TNBC patients had different patterns of outcomes according to TIL and PLR, with the TIL-high/PLR-low group having the lowest rate of disease relapse and death, and the longest distant metastasis-free and overall survivals, while the TIL-low/PLR-high group had the shortest survivals. Our data suggest that the combination of PLR with TIL assessment may enable more accurate prediction of patient outcomes with TNBC.
         datePublished:2022-10-10T00:00:00Z
         dateModified:2022-10-10T00:00:00Z
         pageStart:1
         pageEnd:10
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13058-022-01563-7
         keywords:
            Triple-negative breast cancer
            Tumor-infiltrating lymphocyte
            Regulatory T-cells
            Platelet-to-lymphocyte ratio
            Multiplexed fluorescent immunohistochemistry
            Cancer Research
            Oncology
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-022-01563-7/MediaObjects/13058_2022_1563_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-022-01563-7/MediaObjects/13058_2022_1563_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-022-01563-7/MediaObjects/13058_2022_1563_Fig3_HTML.png
         isPartOf:
            name:Breast Cancer Research
            issn:
               1465-542X
            volumeNumber:24
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hiroko Onagi
               affiliation:
                     name:Juntendo University School of Medicine
                     address:
                        name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yoshiya Horimoto
               affiliation:
                     name:Juntendo University School of Medicine
                     address:
                        name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
                     name:Juntendo University School of Medicine
                     address:
                        name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Asumi Sakaguchi
               affiliation:
                     name:Juntendo University School of Medicine
                     address:
                        name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daiki Ikarashi
               affiliation:
                     name:The Cancer Institute Hospital of Japanese Foundation for Cancer Research
                     address:
                        name:Division of Cancer Immunotherapy Development, Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Naotake Yanagisawa
               affiliation:
                     name:Juntendo University
                     address:
                        name:Medical Technology Innovation Center, Juntendo University, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Takayuki Nakayama
               affiliation:
                     name:National Cancer Center
                     address:
                        name:Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tetsuya Nakatsura
               affiliation:
                     name:National Cancer Center
                     address:
                        name:Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yumiko Ishizuka
               affiliation:
                     name:Juntendo University School of Medicine
                     address:
                        name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ritsuko Sasaki
               affiliation:
                     name:Juntendo University School of Medicine
                     address:
                        name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Junichiro Watanabe
               affiliation:
                     name:Juntendo University School of Medicine
                     address:
                        name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mitsue Saito
               affiliation:
                     name:Juntendo University School of Medicine
                     address:
                        name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Harumi Saeki
               affiliation:
                     name:Juntendo University School of Medicine
                     address:
                        name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Takuo Hayashi
               affiliation:
                     name:Juntendo University School of Medicine
                     address:
                        name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Atsushi Arakawa
               affiliation:
                     name:Juntendo University School of Medicine
                     address:
                        name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Takashi Yao
               affiliation:
                     name:Juntendo University School of Medicine
                     address:
                        name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shigehisa Kitano
               affiliation:
                     name:The Cancer Institute Hospital of Japanese Foundation for Cancer Research
                     address:
                        name:Division of Cancer Immunotherapy Development, Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs
      description:Rating lymphocytes (TILs) are a prognostic marker in breast cancer and high TIL infiltration correlates with better patient outcomes. Meanwhile, parameters involving immune cells in peripheral blood have also been established as prognostic markers. High platelet-to-lymphocyte ratios (PLRs) and neutrophil-to-lymphocyte ratios (NLRs) are related to poor outcomes in breast cancer, but their mechanisms remain unknown. To date, TILs and these parameters have been examined separately. We investigated the relationship between TILs and the peripheral blood markers, PLR and NLR, in the same patients, using surgical specimens from 502 patients with invasive breast carcinoma without preoperative chemotherapy. For analysis of triple-negative breast cancer (TNBC) patient outcomes, 59 patients who received preoperative chemotherapy were also examined. For immune cell profiling, multiplexed fluorescent immunohistochemistry (mfIHC) of CD3, CD4, CD8, FOXP3 and T-bet, was conducted. A positive correlation between PLR and TIL was observed in TNBC (P = 0.013). On mfIHC, tumors in patients with high PLR and NLR contained more CD3+CD4+FOXP3+ T-cells (P = 0.049 and 0.019, respectively), while no trend was observed in CD8+ T-cells. TNBC patients had different patterns of outcomes according to TIL and PLR, with the TIL-high/PLR-low group having the lowest rate of disease relapse and death, and the longest distant metastasis-free and overall survivals, while the TIL-low/PLR-high group had the shortest survivals. Our data suggest that the combination of PLR with TIL assessment may enable more accurate prediction of patient outcomes with TNBC.
      datePublished:2022-10-10T00:00:00Z
      dateModified:2022-10-10T00:00:00Z
      pageStart:1
      pageEnd:10
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13058-022-01563-7
      keywords:
         Triple-negative breast cancer
         Tumor-infiltrating lymphocyte
         Regulatory T-cells
         Platelet-to-lymphocyte ratio
         Multiplexed fluorescent immunohistochemistry
         Cancer Research
         Oncology
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-022-01563-7/MediaObjects/13058_2022_1563_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-022-01563-7/MediaObjects/13058_2022_1563_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13058-022-01563-7/MediaObjects/13058_2022_1563_Fig3_HTML.png
      isPartOf:
         name:Breast Cancer Research
         issn:
            1465-542X
         volumeNumber:24
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hiroko Onagi
            affiliation:
                  name:Juntendo University School of Medicine
                  address:
                     name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yoshiya Horimoto
            affiliation:
                  name:Juntendo University School of Medicine
                  address:
                     name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
                  name:Juntendo University School of Medicine
                  address:
                     name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Asumi Sakaguchi
            affiliation:
                  name:Juntendo University School of Medicine
                  address:
                     name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daiki Ikarashi
            affiliation:
                  name:The Cancer Institute Hospital of Japanese Foundation for Cancer Research
                  address:
                     name:Division of Cancer Immunotherapy Development, Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Naotake Yanagisawa
            affiliation:
                  name:Juntendo University
                  address:
                     name:Medical Technology Innovation Center, Juntendo University, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Takayuki Nakayama
            affiliation:
                  name:National Cancer Center
                  address:
                     name:Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tetsuya Nakatsura
            affiliation:
                  name:National Cancer Center
                  address:
                     name:Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yumiko Ishizuka
            affiliation:
                  name:Juntendo University School of Medicine
                  address:
                     name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ritsuko Sasaki
            affiliation:
                  name:Juntendo University School of Medicine
                  address:
                     name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Junichiro Watanabe
            affiliation:
                  name:Juntendo University School of Medicine
                  address:
                     name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mitsue Saito
            affiliation:
                  name:Juntendo University School of Medicine
                  address:
                     name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Harumi Saeki
            affiliation:
                  name:Juntendo University School of Medicine
                  address:
                     name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Takuo Hayashi
            affiliation:
                  name:Juntendo University School of Medicine
                  address:
                     name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Atsushi Arakawa
            affiliation:
                  name:Juntendo University School of Medicine
                  address:
                     name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Takashi Yao
            affiliation:
                  name:Juntendo University School of Medicine
                  address:
                     name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shigehisa Kitano
            affiliation:
                  name:The Cancer Institute Hospital of Japanese Foundation for Cancer Research
                  address:
                     name:Division of Cancer Immunotherapy Development, Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research
      issn:
         1465-542X
      volumeNumber:24
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Juntendo University School of Medicine
      address:
         name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:Juntendo University School of Medicine
      address:
         name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:Juntendo University School of Medicine
      address:
         name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:Juntendo University School of Medicine
      address:
         name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:The Cancer Institute Hospital of Japanese Foundation for Cancer Research
      address:
         name:Division of Cancer Immunotherapy Development, Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
         type:PostalAddress
      name:Juntendo University
      address:
         name:Medical Technology Innovation Center, Juntendo University, Tokyo, Japan
         type:PostalAddress
      name:National Cancer Center
      address:
         name:Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan
         type:PostalAddress
      name:National Cancer Center
      address:
         name:Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan
         type:PostalAddress
      name:Juntendo University School of Medicine
      address:
         name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:Juntendo University School of Medicine
      address:
         name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:Juntendo University School of Medicine
      address:
         name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:Juntendo University School of Medicine
      address:
         name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:Juntendo University School of Medicine
      address:
         name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:Juntendo University School of Medicine
      address:
         name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:Juntendo University School of Medicine
      address:
         name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:Juntendo University School of Medicine
      address:
         name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
         type:PostalAddress
      name:The Cancer Institute Hospital of Japanese Foundation for Cancer Research
      address:
         name:Division of Cancer Immunotherapy Development, Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hiroko Onagi
      affiliation:
            name:Juntendo University School of Medicine
            address:
               name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Yoshiya Horimoto
      affiliation:
            name:Juntendo University School of Medicine
            address:
               name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
            name:Juntendo University School of Medicine
            address:
               name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Asumi Sakaguchi
      affiliation:
            name:Juntendo University School of Medicine
            address:
               name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Daiki Ikarashi
      affiliation:
            name:The Cancer Institute Hospital of Japanese Foundation for Cancer Research
            address:
               name:Division of Cancer Immunotherapy Development, Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Naotake Yanagisawa
      affiliation:
            name:Juntendo University
            address:
               name:Medical Technology Innovation Center, Juntendo University, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Takayuki Nakayama
      affiliation:
            name:National Cancer Center
            address:
               name:Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan
               type:PostalAddress
            type:Organization
      name:Tetsuya Nakatsura
      affiliation:
            name:National Cancer Center
            address:
               name:Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan
               type:PostalAddress
            type:Organization
      name:Yumiko Ishizuka
      affiliation:
            name:Juntendo University School of Medicine
            address:
               name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Ritsuko Sasaki
      affiliation:
            name:Juntendo University School of Medicine
            address:
               name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Junichiro Watanabe
      affiliation:
            name:Juntendo University School of Medicine
            address:
               name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Mitsue Saito
      affiliation:
            name:Juntendo University School of Medicine
            address:
               name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Harumi Saeki
      affiliation:
            name:Juntendo University School of Medicine
            address:
               name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Takuo Hayashi
      affiliation:
            name:Juntendo University School of Medicine
            address:
               name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Atsushi Arakawa
      affiliation:
            name:Juntendo University School of Medicine
            address:
               name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Takashi Yao
      affiliation:
            name:Juntendo University School of Medicine
            address:
               name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:Shigehisa Kitano
      affiliation:
            name:The Cancer Institute Hospital of Japanese Foundation for Cancer Research
            address:
               name:Division of Cancer Immunotherapy Development, Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
      name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
      name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
      name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
      name:Division of Cancer Immunotherapy Development, Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan
      name:Medical Technology Innovation Center, Juntendo University, Tokyo, Japan
      name:Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan
      name:Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan
      name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
      name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
      name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
      name:Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan
      name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
      name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
      name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
      name:Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan
      name:Division of Cancer Immunotherapy Development, Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

External Links {🔗}(131)

• How much does https://www.springernature.com/gp/authors pull in?
• Earnings of https://link.springernature.com/home/
• Financial intake of https://order.springer.com/public/cart
• Learn how profitable https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research is on a monthly basis
• What is the earnings of https://breast-cancer-research.biomedcentral.com/about?
• What's the total monthly financial gain of https://submission.nature.com/new-submission/13058/3?
• How much revenue does https://doi.org/10.1016%2FS1470-2045%2817%2930904-X bring in?
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Tumour-infiltrating%20lymphocytes%20and%20prognosis%20in%20different%20subtypes%20of%20breast%20cancer%3A%20a%20pooled%20analysis%20of%203771%20patients%20treated%20with%20neoadjuvant%20therapy&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2817%2930904-X&volume=19&issue=1&pages=40-50&publication_year=2018&author=Denkert%2CC&author=Minckwitz%2CG&author=Darb-Esfahani%2CS&author=Lederer%2CB&author=Heppner%2CBI&author=Weber%2CKE?
• How much does https://doi.org/10.1200%2FJCO.2013.55.0491 net monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Prognostic%20value%20of%20tumor-infiltrating%20lymphocytes%20in%20triple-negative%20breast%20cancers%20from%20two%20phase%20iii%20randomized%20adjuvant%20breast%20cancer%20trials%3A%20ECOG%202197%20and%20ECOG%201199&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2013.55.0491&volume=32&issue=27&pages=2959-2966&publication_year=2014&author=Adams%2CS&author=Gray%2CRJ&author=Demaria%2CS&author=Goldstein%2CL&author=Perez%2CEA&author=Shulman%2CLN pull in monthly?
• Learn how profitable https://doi.org/10.1056%2FNEJMoa1809615 is on a monthly basis
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Atezolizumab%20and%20nab-paclitaxel%20in%20advanced%20triple-negative%20breast%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1809615&volume=379&issue=22&pages=2108-2121&publication_year=2018&author=Schmid%2CP&author=Adams%2CS&author=Rugo%2CHS&author=Schneeweiss%2CA&author=Barrios%2CCH&author=Iwata%2CH
• How much revenue does https://doi.org/10.1016%2FS0140-6736%2820%2932531-9 produce monthly?
• http://scholar.google.com/scholar_lookup?&title=Pembrolizumab%20plus%20chemotherapy%20versus%20placebo%20plus%20chemotherapy%20for%20previously%20untreated%20locally%20recurrent%20inoperable%20or%20metastatic%20triple-negative%20breast%20cancer%20%28KEYNOTE-355%29%3A%20a%20randomised%2C%20placebo-controlled%2C%20double-blind%2C%20phase%203%20clinical%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2820%2932531-9&volume=396&issue=10265&pages=1817-1828&publication_year=2020&author=Cortes%2CJ&author=Cescon%2CDW&author=Rugo%2CHS&author=Nowecki%2CZ&author=Im%2CS-A&author=Yusof%2CMM's financial summary
• What's the financial intake of https://doi.org/10.1177%2F1758835920940928?
• What's http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20predictive%20factors%20of%20immune%20checkpoint%20inhibitors%20in%20metastatic%20breast%20cancer%3A%20a%20systematic%20review%20and%20meta-analysis&journal=Ther%20Adv%20Med%20Oncol&doi=10.1177%2F1758835920940928&volume=12&pages=1758835920940928-1758835920940928&publication_year=2020&author=Zou%2CY&author=Zou%2CX&author=Zheng%2CS&author=Tang%2CH&author=Zhang%2CL&author=Liu%2CP's gross income?
• What's the total monthly financial gain of https://doi.org/10.1111%2Fcas.14500?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Microsatellite%20instability%20and%20mismatch%20repair%20protein%20expressions%20in%20lymphocyte-predominant%20breast%20cancer&journal=Cancer%20Sci&doi=10.1111%2Fcas.14500&volume=111&issue=7&pages=2647-2654&publication_year=2020&author=Horimoto%2CY&author=Thinzar%20Hlaing%2CM&author=Saeki%2CH&author=Kitano%2CS&author=Nakai%2CK&author=Sasaki%2CR
• What is the earnings of https://doi.org/10.21873%2Fanticanres.14985?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Molecular%20characteristics%20of%20lymphocyte-predominant%20triple-negative%20breast%20cancer&journal=Anticancer%20Res&doi=10.21873%2Fanticanres.14985&volume=41&issue=4&pages=2133-2140&publication_year=2021&author=Sasaki%2CR&author=Horimoto%2CY&author=Yanai%2CY&author=Kurisaki-Arakawa%2CA&author=Arakawa%2CA&author=Nakai%2CK
• What's the income of https://doi.org/10.1093/jnci/djab004?
• Check the income stats for https://doi.org/10.1093%2Fjnci%2Fdjab004
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34097070 produce monthly?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634452 pull in monthly?
• How much money does http://scholar.google.com/scholar_lookup?&title=Atezolizumab%20and%20nab-paclitaxel%20in%20advanced%20triple-negative%20breast%20cancer%3A%20biomarker%20evaluation%20of%20the%20impassion130%20study&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjab004&publication_year=2021&author=Emens%2CLA&author=Molinero%2CL&author=Loi%2CS&author=Rugo%2CHS&author=Schneeweiss%2CA&author=Di%C3%A9ras%2CV generate?
• How much does http://scholar.google.com/scholar_lookup?&title=Prognostic%20role%20of%20neutrophil-to-lymphocyte%20ratio%20in%20breast%20cancer%3A%20a%20systematic%20review%20and%20meta-analysis&journal=Breast%20Cancer%20Res&doi=10.1186%2Fs13058-016-0794-1&volume=19&issue=1&publication_year=2017&author=Ethier%2CJL&author=Desautels%2CD&author=Templeton%2CA&author=Shah%2CPS&author=Amir%2CE bring in each month?
• Learn how profitable https://doi.org/10.1038%2Fbjc.2015.183 is on a monthly basis
• http://scholar.google.com/scholar_lookup?&title=Utility%20of%20pre-treatment%20neutrophil-lymphocyte%20ratio%20and%20platelet-lymphocyte%20ratio%20as%20prognostic%20factors%20in%20breast%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.2015.183&volume=113&issue=1&pages=150-158&publication_year=2015&author=Koh%2CCH&author=Bhoo-Pathy%2CN&author=Ng%2CKL&author=Jabir%2CRS&author=Tan%2CGH&author=See%2CMH's revenue stream
• How much profit does http://scholar.google.com/scholar_lookup?&title=Pretreatment%20neutrophil-to-lymphocyte%20ratio%20is%20correlated%20with%20response%20to%20neoadjuvant%20chemotherapy%20as%20an%20independent%20prognostic%20indicator%20in%20breast%20cancer%20patients%3A%20a%20retrospective%20study&journal=BMC%20Cancer&doi=10.1186%2Fs12885-016-2352-8&volume=16&pages=320-320&publication_year=2016&author=Chen%2CY&author=Chen%2CK&author=Xiao%2CX&author=Nie%2CY&author=Qu%2CS&author=Gong%2CC generate?
• What's the monthly income of https://doi.org/10.1038%2Fbjc.2014.163?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=The%20elevated%20preoperative%20platelet-to-lymphocyte%20ratio%20predicts%20poor%20prognosis%20in%20breast%20cancer%20patients&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.2014.163&volume=110&issue=10&pages=2524-2530&publication_year=2014&author=Krenn-Pilko%2CS&author=Langsenlehner%2CU&author=Thurner%2CEM&author=Stojakovic%2CT&author=Pichler%2CM&author=Gerger%2CA?
• What's the total monthly financial gain of https://doi.org/10.1155%2F2017%2F9503025?
• http://scholar.google.com/scholar_lookup?&title=High%20Platelet-to-lymphocyte%20ratio%20predicts%20poor%20prognosis%20and%20clinicopathological%20characteristics%20in%20patients%20with%20breast%20cancer%3A%20a%20meta-analysis&journal=BioMed%20Res%20Int&doi=10.1155%2F2017%2F9503025&volume=2017&publication_year=2017&author=Zhang%2CM&author=Huang%2CX-z&author=Song%2CY-x&author=Gao%2CP&author=Sun%2CJ-x&author=Wang%2CZ-n's total income per month
• See how much https://doi.org/10.1245%2Fs10434-015-4934-0 makes per month
• How much does http://scholar.google.com/scholar_lookup?&title=Predictive%20value%20of%20neutrophil%2Flymphocyte%20ratio%20for%20efficacy%20of%20preoperative%20chemotherapy%20in%20triple-negative%20breast%20cancer&journal=Ann%20Surg%20Oncol&doi=10.1245%2Fs10434-015-4934-0&volume=23&issue=4&pages=1104-1110&publication_year=2016&author=Asano%2CY&author=Kashiwagi%2CS&author=Onoda%2CN&author=Noda%2CS&author=Kawajiri%2CH&author=Takashima%2CT rake in every month?
• How much does http://scholar.google.com/scholar_lookup?&title=Neutrophil-to-lymphocyte%20ratio%20and%20histological%20type%20might%20predict%20clinical%20responses%20to%20eriburin-based%20treatment%20in%20patients%20with%20metastatic%20breast%20cancer&journal=Breast%20Cancer&doi=10.1007%2Fs12282-020-01069-0&volume=27&issue=4&pages=732-738&publication_year=2020&author=Myojin%2CM&author=Horimoto%2CY&author=Ito%2CM&author=Kitano%2CS&author=Ishizuka%2CY&author=Sasaki%2CR make?
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35002243?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738870 earn?
• How much income is http://scholar.google.com/scholar_lookup?&title=Clinicopathological%20features%20related%20to%20the%20efficacy%20of%20CDK4%2F6%20inhibitor-based%20treatments%20in%20metastatic%20breast%20cancer&journal=Breast%20Cancer&volume=16&publication_year=2022&author=Shikanai%2CA&author=Horimoto%2CY&author=Ishizuka%2CY&author=Uomori%2CT&author=Nakai%2CK&author=Arakawa%2CA earning monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Predictive%20impact%20of%20absolute%20lymphocyte%20counts%20for%20progression-free%20survival%20in%20human%20epidermal%20growth%20factor%20receptor%202-positive%20advanced%20breast%20cancer%20treated%20with%20pertuzumab%20and%20trastuzumab%20plus%20eribulin%20or%20nab-paclitaxel&journal=BMC%20Cancer&doi=10.1186%2Fs12885-018-4888-2&volume=18&issue=1&pages=982-982&publication_year=2018&author=Araki%2CK&author=Ito%2CY&author=Fukada%2CI&author=Kobayashi%2CK&author=Miyagawa%2CY&author=Imamura%2CM net monthly?
• Learn about the earnings of https://doi.org/10.1158%2F0008-5472.CAN-08-3845
• How much does http://scholar.google.com/scholar_lookup?&title=Lymphopenia%20as%20a%20prognostic%20factor%20for%20overall%20survival%20in%20advanced%20carcinomas%2C%20sarcomas%2C%20and%20lymphomas&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-08-3845&volume=69&issue=13&pages=5383-5391&publication_year=2009&author=Ray-Coquard%2CI&author=Cropet%2CC&author=Glabbeke%2CM&author=Sebban%2CC&author=Cesne%2CA&author=Judson%2CI bring in each month?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=A%20maintained%20absolute%20lymphocyte%20count%20predicts%20the%20overall%20survival%20benefit%20from%20eribulin%20therapy%2C%20including%20eribulin%20re-administration%2C%20in%20HER2-negative%20advanced%20breast%20cancer%20patients%3A%20a%20single-institutional%20experience&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-020-05626-1&volume=181&issue=1&pages=211-220&publication_year=2020&author=Watanabe%2CJ&author=Saito%2CM&author=Horimoto%2CY&author=Nakamoto%2CS
• Get to know https://doi.org/10.1158%2F1078-0432.CCR-03-0760's earnings
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=The%20potential%20role%20of%20neutrophils%20in%20promoting%20the%20metastatic%20phenotype%20of%20tumors%20releasing%20interleukin-8&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-03-0760&volume=10&issue=15&pages=4895-4900&publication_year=2004&author=Larco%2CJE&author=Wuertz%2CBRK&author=Furcht%2CLT?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2821114 income
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Immunosuppression%20by%20activated%20human%20neutrophils.%20Dependence%20on%20the%20myeloperoxidase%20system&journal=J%20Immunol&volume=139&issue=7&pages=2406-2413&publication_year=1987&author=el-Hag%2CA&author=Clark%2CRA produce monthly?
• What's the profit of https://doi.org/10.1182%2Fblood-2004-06-2272?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Platelets%20and%20fibrin%28ogen%29%20increase%20metastatic%20potential%20by%20impeding%20natural%20killer%20cell%E2%80%93mediated%20elimination%20of%20tumor%20cells&journal=Blood&doi=10.1182%2Fblood-2004-06-2272&volume=105&issue=1&pages=178-185&publication_year=2005&author=Palumbo%2CJS&author=Talmage%2CKE&author=Massari%2CJV&author=Jeunesse%2CCM&author=Flick%2CMJ&author=Kombrinck%2CKW?
• Get to know https://doi.org/10.1111%2Fj.1538-7836.2010.04131.x's earnings
• How much does http://scholar.google.com/scholar_lookup?&title=The%20platelet%20contribution%20to%20cancer%20progression&journal=J%20Thromb%20Haemost&doi=10.1111%2Fj.1538-7836.2010.04131.x&volume=9&issue=2&pages=237-249&publication_year=2011&author=Bambace%2CNM&author=Holmes%2CCE gross monthly?
• How much does https://doi.org/10.1371%2Fjournal.pone.0026125 make?
• http://scholar.google.com/scholar_lookup?&title=Platelet%20adhesion%20and%20degranulation%20induce%20pro-survival%20and%20pro-angiogenic%20signalling%20in%20ovarian%20cancer%20cells&journal=PLoS%20ONE&doi=10.1371%2Fjournal.pone.0026125&volume=6&issue=10&publication_year=2011&author=Egan%2CK&author=Crowley%2CD&author=Smyth%2CP&author=O%27Toole%2CS&author=Spillane%2CC&author=Martin%2CC's total income per month
• Learn how profitable https://doi.org/10.3390%2Fcancers11070911 is on a monthly basis
• How much does http://scholar.google.com/scholar_lookup?&title=Decoding%20immune%20heterogeneity%20of%20triple%20negative%20breast%20cancer%20and%20its%20association%20with%20systemic%20inflammation&journal=Cancers&doi=10.3390%2Fcancers11070911&volume=11&issue=7&publication_year=2019&author=Romero-Cordoba%2CS&author=Meneghini%2CE&author=Sant%2CM&author=Iorio%2CMV&author=Sfondrini%2CL&author=Paolini%2CB rake in every month?
• http://scholar.google.com/scholar_lookup?&title=The%20prognostic%20and%20predictive%20value%20of%20tumor-infiltrating%20lymphocytes%20and%20hematologic%20parameters%20in%20patients%20with%20breast%20cancer&journal=BMC%20Cancer&doi=10.1186%2Fs12885-018-4832-5&volume=18&issue=1&publication_year=2018&author=Lee%2CKH&author=Kim%2CEY&author=Yun%2CJS&author=Park%2CYL&author=Do%2CS-I&author=Chae%2CSW's total income per month
• What's the monthly income of https://doi.org/10.1093%2Fannonc%2Fmdu450?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=The%20evaluation%20of%20tumor-infiltrating%20lymphocytes%20%28TILs%29%20in%20breast%20cancer%3A%20recommendations%20by%20an%20International%20TILs%20Working%20Group%202014&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdu450&volume=26&issue=2&pages=259-271&publication_year=2015&author=Salgado%2CR&author=Denkert%2CC&author=Demaria%2CS&author=Sirtaine%2CN&author=Klauschen%2CF&author=Pruneri%2CG
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Plasma%20cell%20infiltration%20and%20treatment%20effect%20in%20breast%20cancer%20patients%20treated%20with%20neoadjuvant%20chemotherapy&journal=Breast%20Cancer%20Res&doi=10.1186%2Fs13058-021-01477-w&volume=23&issue=1&publication_year=2021&author=Sakaguchi%2CA&author=Horimoto%2CY&author=Onagi%2CH&author=Ikarashi%2CD&author=Nakayama%2CT&author=Nakatsura%2CT
• How profitable is https://doi.org/10.1158%2F0008-5472.CAN-09-2123?
• How much does http://scholar.google.com/scholar_lookup?&title=Platelet-derived%20transforming%20growth%20factor-beta%20down-regulates%20NKG2D%20thereby%20inhibiting%20natural%20killer%20cell%20antitumor%20reactivity&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-09-2123&volume=69&issue=19&pages=7775-7783&publication_year=2009&author=Kopp%2CHG&author=Placke%2CT&author=Salih%2CHR gross monthly?
• Learn how profitable https://doi.org/10.1159%2F000323936 is on a monthly basis
• How much money does http://scholar.google.com/scholar_lookup?&title=Modulation%20of%20natural%20killer%20cell%20anti-tumor%20reactivity%20by%20platelets&journal=J%20Innate%20Immun&doi=10.1159%2F000323936&volume=3&issue=4&pages=374-382&publication_year=2011&author=Placke%2CT&author=Kopp%2CHG&author=Salih%2CHR generate?
• https://doi.org/10.1189%2Fjlb.0907615 income
• How much does http://scholar.google.com/scholar_lookup?&title=Platelet-lymphocyte%20cross-talk&journal=J%20Leukoc%20Biol&doi=10.1189%2Fjlb.0907615&volume=83&issue=5&pages=1069-1078&publication_year=2008&author=Li%2CN make?
• How much does https://doi.org/10.4049%2Fjimmunol.174.5.2680 gross monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Platelet%20factor%204%20differentially%20modulates%20CD4%2BCD25%2B%20%28regulatory%29%20versus%20CD4%2BCD25-%20%28nonregulatory%29%20T%20cells&journal=J%20Immunol&doi=10.4049%2Fjimmunol.174.5.2680&volume=174&issue=5&pages=2680-2686&publication_year=2005&author=Liu%2CCY&author=Battaglia%2CM&author=Lee%2CSH&author=Sun%2CQH&author=Aster%2CRH&author=Visentin%2CGP pull in monthly?
• Discover the revenue of https://doi.org/10.1016%2Fj.jhep.2021.07.032
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Regulatory%20T-cell%20and%20neutrophil%20extracellular%20trap%20interaction%20contributes%20to%20carcinogenesis%20in%20non-alcoholic%20steatohepatitis&journal=J%20Hepatol&doi=10.1016%2Fj.jhep.2021.07.032&volume=75&issue=6&pages=1271-1283&publication_year=2021&author=Wang%2CH&author=Zhang%2CH&author=Wang%2CY&author=Brown%2CZJ&author=Xia%2CY&author=Huang%2CZ
• How profitable is https://doi.org/10.1080%2F2162402X.2017.1356965?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Tumor-associated%20neutrophils%20induce%20apoptosis%20of%20non-activated%20CD8%20T-cells%20in%20a%20TNF%CE%B1%20and%20NO-dependent%20mechanism%2C%20promoting%20a%20tumor-supportive%20environment&journal=Oncoimmunology&doi=10.1080%2F2162402X.2017.1356965&volume=6&issue=11&publication_year=2017&author=Michaeli%2CJ&author=Shaul%2CME&author=Mishalian%2CI&author=Hovav%2CAH&author=Levy%2CL&author=Zolotriov%2CL
• Find out how much http://scholar.google.com/scholar_lookup?&title=Immune%20microenvironment%20in%20different%20molecular%20subtypes%20of%20ductal%20breast%20carcinoma&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-020-05954-2&volume=185&issue=2&pages=261-279&publication_year=2021&author=Sadeghalvad%2CM&author=Mohammadi-Motlagh%2CHR&author=Rezaei%2CN earns monthly
• How much does https://citation-needed.springer.com/v2/references/10.1186/s13058-022-01563-7?format=refman&flavour=references pull in?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hiroko%20Onagi generate monthly?
• What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hiroko%20Onagi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yoshiya%20Horimoto?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yoshiya%20Horimoto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
• What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Asumi%20Sakaguchi?
• Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Asumi%20Sakaguchi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Daiki%20Ikarashi's total income per month
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Daiki%20Ikarashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Naotake%20Yanagisawa's earnings
• How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Naotake%20Yanagisawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takayuki%20Nakayama generate monthly?
• What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takayuki%20Nakayama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tetsuya%20Nakatsura making per month?
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tetsuya%20Nakatsura%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yumiko%20Ishizuka makes per month
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yumiko%20Ishizuka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ritsuko%20Sasaki
• What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ritsuko%20Sasaki%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Junichiro%20Watanabe net monthly?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Junichiro%20Watanabe%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mitsue%20Saito
• How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mitsue%20Saito%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Harumi%20Saeki earn?
• How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Harumi%20Saeki%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takuo%20Hayashi earns monthly
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takuo%20Hayashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Atsushi%20Arakawa bring in?
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Atsushi%20Arakawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takashi%20Yao generate?
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takashi%20Yao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shigehisa%20Kitano?
• Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shigehisa%20Kitano%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much cash flow does https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-022-01563-7/MediaObjects/13058_2022_1563_MOESM1_ESM.xlsx have monthly?
• How much revenue does https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-022-01563-7/MediaObjects/13058_2022_1563_MOESM2_ESM.tif generate?
• How much profit is https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-022-01563-7/MediaObjects/13058_2022_1563_MOESM3_ESM.tif making per month?
• https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-022-01563-7/MediaObjects/13058_2022_1563_MOESM4_ESM.tif's financial summary
• How much money does https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-022-01563-7/MediaObjects/13058_2022_1563_MOESM5_ESM.tif make?
• How much does https://static-content.springer.com/esm/art%3A10.1186%2Fs13058-022-01563-7/MediaObjects/13058_2022_1563_MOESM6_ESM.tif gross monthly?
• Find out how much http://creativecommons.org/licenses/by/4.0/ earns monthly
• How much profit does http://creativecommons.org/publicdomain/zero/1.0/ make?
• Profit of https://s100.copyright.com/AppDispatchServlet?title=High%20platelet-to-lymphocyte%20ratios%20in%20triple-negative%20breast%20cancer%20associates%20with%20immunosuppressive%20status%20of%20TILs&author=Hiroko%20Onagi%20et%20al&contentID=10.1186%2Fs13058-022-01563-7©right=The%20Author%28s%29&publication=1465-542X&publicationDate=2022-10-10&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0
• How much profit does https://crossmark.crossref.org/dialog/?doi=10.1186/s13058-022-01563-7 generate?
• What are the earnings of https://citation-needed.springer.com/v2/references/10.1186/s13058-022-01563-7?format=refman&flavour=citation?
• How much cash flow does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral have monthly?
• What's the revenue for https://www.springernature.com/gp/products?
• What's the financial outcome of https://www.springernature.com/gp/librarians?
• What's the monthly income of https://www.springernature.com/gp/societies?
• How much does https://www.springernature.com/gp/partners earn?
• How much does https://www.springer.com/ rake in every month?
• What's the financial intake of https://www.nature.com/?
• What's the financial gain of https://www.biomedcentral.com/?
• https://www.palgrave.com/ income
• What's the monthly money flow for https://www.apress.com/?
• What's the revenue for https://www.springernature.com/gp/legal/ccpa?
• How much money does https://www.springernature.com/gp/info/accessibility make?
• Get to know what's the income of https://support.springernature.com/en/support/home
• What's the monthly income of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
• What's the financial intake of https://www.springernature.com/?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref